Philippines - English - FDA (Food And Drug Administration)

vet specialists, inc.; distributor: vet specialists, inc. - multivitamins , minerals , amino acids (vet.) - oral solution - formulation: each liter contains: vitamin a (as retinol proportionate)-12,000 iu threonine-2 mg folic acid-3.2 mcg colecalciferol (vitamin d3)-3,000 iu thiamine hydrochloride (vitamin b1)-2mg potassium (as potassium chloride) -.0.833 mg dexapanthenol (vitamin b5) - 4mg dl-methionine-1.371 mg iron (as ferric ammonium citrate)-.250 mcg ascorbic acid-3.5 mg pyridoxine hydrochloride (vitaminb6)- 1.25 mg zinc (as zinc chloride)-.0.100 mg all-rac-a-tocopheryl acetate (vitamin e acetate) -3.25 mg menadion sodium bisulphate (vitamin k3) -1 mg copper (aas copper chloride dihydrate)- .0.033 mg threonine - 2.057 mg lysine (as hydrochloride) -2.743 mg tryptophan -686 mcg l-valine-2.74 mg calcium (as calcium chloride dihydrate)-60 mcg isoleucine-2.4 mg sodium (as sodium chloride) -60 mcg

United States - English - NLM (National Library of Medicine)

rebel distributors corp - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 250 mg - levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. this product should not be administered to patients who have previously exhibited hypersensitivity to levetiracetam or any of the inactive ingredients in levetiracetam tablets. the abuse and dependence potential of levetiracetam has not been evaluated in human studies.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 500 mg - levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. this product should not be administered to patients who have previously exhibited hypersensitivity to levetiracetam or any of the inactive ingredients in levetiracetam tablets. the abuse and dependence potential of levetiracetam has not been evaluated in human studies.

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 250 mg - levetiracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. levetiracetam tablets are indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam tablets are indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy. levetiracetam tablets are contraindicated in patients with a hypersensitivity to levetiracetam. reactions have included anaphylaxis and angioedema [see warnings and precautions ( 5.4)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), including levetiracetam, during pregnancy. encourage women who are taking levetiracetam during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - levetiracetam, quantity: 100 mg/ml - solution - excipient ingredients: propyl hydroxybenzoate; purified water; ammonium glycyrrhizinate; acesulfame potassium; methyl hydroxybenzoate; sodium citrate dihydrate; glycerol; citric acid monohydrate; maltitol; flavour - levetiracetam gh oral solution is indicated for:,? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment,of partial onset seizures with or without secondary generalisation,,? monotherapy in the treatment of partial onset seizures, with or without secondary,generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12,years of age with juvenile myoclonic epilepsy (jme),,? add-on therapy in the treatment of primary generalized tonic clonic (pgtc) seizures in adults and,children from 4 years of age with idiopathic generalized epilepsy (ige)

United States - English - NLM (National Library of Medicine)

rebel distributors corp - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. this product should not be administered to patients who have previously exhibited hypersensitivity to levetiracetam or any of the inactive ingredients in levetiracetam tablets. the abuse and dependence potential of levetiracetam has not been evaluated in human studies.

Philippines - English - FDA (Food And Drug Administration)

vet specialists, inc.; distributor: vet specialists, inc. - oxytocin (vet.) - solution for injection (im/iv) - 10 iu/ ml

Philippines - English - FDA (Food And Drug Administration)

vet specialists, inc.; distributor: vet specialists, inc. - ivermectin (vet.) - solution for injection (sc) - 10 mg/ml

Philippines - English - FDA (Food And Drug Administration)

vet specialists, inc.; distributor: vet specialists, inc. - peni-dhs 20,25 - suspension for injection (im) - 200,000 iu/250mg per ml

Philippines - English - FDA (Food And Drug Administration)

vet specialists, inc.; distributor: vet specialists, inc. - d-cloprostenol (as sodium) (vet.) - solution for injection (im) - 75mcg/ml